Globus Medical holds the cleaner structural position, with the lead spread across growth and valuation. SUSS MicroTec SE still has the edge on stability, which keeps the comparison from looking entirely one-sided. In the market, SUSS MicroTec SE carries the stronger setup — intact trend against Globus Medical's broken trend. That leaves a split case: the structural lead stays with Globus Medical, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (GMED: Russell 1000, SMHN.DE: HDAX).
The lead is spread across growth and valuation, rather than sitting in one isolated gap. The overall score gap is 36 points in favour of Globus Medical, Inc..
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
Most of the shared profile comes through recent revenue growth and investment intensity.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Globus Medical, Inc. looks stronger both structurally and on relative valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where GMED and SMHN.DE each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
One company is still expanding while the other is contracting, which creates a very wide growth split.
On the market side, SUSS MicroTec SE carries the stronger trend while Globus Medical's trend has broken — the market setup does not confirm the structural advantage.
The lead is built on both growth and valuation — though stability still provides a counterweight.
Break down the GMED vs SMHN.DE comparison across all dimensions with the full interactive tool.
Explore how GMED and SMHN.DE each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.